Nasopharyngeal foam swabs and their ability to collect high volumes of mucus and saliva and release them into the transport medium with a high recovery rate are paramount in detecting bacterial and viral infections. The US FDA and CDC recommend polyurethane foam swabs for PCR detection of most respiratory viruses, including SARS-CoV-2 (COVID-19), rhinoviruses and enteroviruses (Picornaviridae), influenza viruses (Orthomyxoviridae), parainfluenza, metapneumoviruses and respiratory syncytial viruses (Paramyxoviridae), coronaviruses (Coronaviridae) and bacterial infections caused by Streptococcus pneumoniae (pneumonia) and Streptococcus pyogenes (strep throat).
Foamtec Medical Nasopharyngeal swabs utilize Foamtec developed polyurethane foam technology that provides an exceptional surface area to capture a maximum quantity of target fluids while not bonding to those fluids providing high subject recovery.
Foamtec swabs are safe, non-cytotoxic, and sterilized by a validated gamma irradiation process. Foamtec Medical proprietary swab cleaning and validated sterilization processes ensure no background from RNAse, no harmful additives and gases, and other contaminants for accurate, safe test results. Comfort in Nasopharyngeal swabbing is achieved with long, slender, flexible handles keeping patient discomfort to a minimum while reaching remote areas of the nasal septum and oral cavities.
The plastic handle is engineered with an 80mm snap point to facilitate depositing the swab tip into a transport tube.
• The High surface area captures the maximum
amount of mucus and saliva.
• High release % of captured samples.
• Validated gamma-irradiated sterile, clean swab surfaces.
• Thin, high flexibility handles .
• Ability to reach remote areas of the nasal septum and oral cavities.
• High recovery rates of body fluids for accurate test results.
• Maximum patient comfort.